β2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration

被引:56
作者
King, SL [1 ]
Caldarone, BJ [1 ]
Picciotto, MR [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA
关键词
dopamine; pimozide; nAChR; behavioral sensitization; knockout mice;
D O I
10.1016/j.neuropharm.2004.06.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Activation of the mesolimbic dopamine system is a critical component underlying addictive behaviors, including smoking. It has been hypothesized that the initial effect of nicotine on the dopamine system is to activate high affinity nicotinic acetylcholine receptors (nAChRs) containing the beta2 subunit, but that these receptors rapidly desensitize and are not critical for ongoing dopaminergic activation. To clarify the role of beta2-subunit-containing (beta2*) nAChRs in activation of the dopamine system and subsequent locomotor activation by repeated nicotine administration, C57BL/6J (B6) mice were administered 200 mug/ml of nicotine in the drinking water and the onset of locomotor activation was measured. B6 mice showed an increase in locomotor activity in response to chronic nicotine which was blocked by oral administration of the dopamine receptor antagonist pimozide. Knockout mice lacking the beta2 subunit of the nAChR did not show locomotor activation in response to chronic nicotine exposure, suggesting that beta2* nAChRs are critical for ongoing activation of the dopamine system by chronic nicotine administration and the resulting locomotor activation in mice. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 38 条
[1]   THE EFFECTS OF ACUTE AND REPEATED NICOTINE TREATMENT ON NUCLEUS-ACCUMBENS DOPAMINE AND LOCOMOTOR-ACTIVITY [J].
BENWELL, MEM ;
BALFOUR, DJK .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :849-856
[2]  
Champtiaux N, 2003, J NEUROSCI, V23, P7820
[3]   Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice [J].
Champtiaux, N ;
Han, ZY ;
Bessis, A ;
Rossi, FM ;
Zoli, M ;
Marubio, L ;
McIntosh, JM ;
Changeux, JP .
JOURNAL OF NEUROSCIENCE, 2002, 22 (04) :1208-1217
[4]  
CLARKE PBS, 1988, J PHARMACOL EXP THER, V246, P701
[5]   THE EFFECTS OF NICOTINE ON LOCOMOTOR-ACTIVITY IN NON-TOLERANT AND TOLERANT RATS [J].
CLARKE, PBS ;
KUMAR, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (02) :329-337
[6]  
Cui CH, 2003, J NEUROSCI, V23, P11045
[7]   IS THE DOPAMINERGIC SYSTEM INVOLVED IN THE CENTRAL EFFECTS OF NICOTINE IN MICE [J].
DAMAJ, MI ;
MARTIN, BR .
PSYCHOPHARMACOLOGY, 1993, 111 (01) :106-108
[8]   Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice [J].
Gäddnäs, H ;
Pietilä, K ;
Ahtee, L .
BEHAVIOURAL BRAIN RESEARCH, 2000, 113 (1-2) :65-72
[9]   Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water [J].
Gäddnäs, H ;
Pietilä, K ;
Piepponen, P ;
Ahtee, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (04) :497-503
[10]   Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum [J].
Grady, SR ;
Meinerz, NM ;
Cao, J ;
Reynolds, AM ;
Picciotto, MR ;
Changeux, JP ;
McIntosh, JM ;
Marks, MJ ;
Collins, AC .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :258-268